Biotechnology Stocks
| # | 7 Derniers Jours | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3674 |  KRRO Korro Bio, Inc. - Common Stock | 10.58 USD | +0.86% | +6.87% | -17.34% | -72.80% | 155.80 M USD | ||
| 3676 |  MOLN Molecular Partners AG - American Depositary Shares | 3.81 USD | +0.79% | -2.81% | -8.85% | +3.53% | 153.83 M USD | ||
| 3677 |  NERV Minerva Neurosciences, Inc - Common Stock | 3.22 USD | -1.53% | -2.13% | -21.46% | +33.06% | 153.75 M USD | ||
| 3682 |  ABOS Acumen Pharmaceuticals, Inc. - Common Stock | 2.10 USD | 0.00% | 0.00% | -24.73% | -8.30% | 151.87 M USD | ||
| 3695 |  CDXS Codexis, Inc. - Common Stock | 1.36 USD | -3.55% | -2.16% | -4.23% | -51.43% | 148.93 M USD | ||
| 3700 |  VYGR Voyager Therapeutics, Inc. - Common Stock | 2.37 USD | -4.05% | -12.87% | -25.94% | -49.03% | 146.03 M USD | ||
| 3706 |  ARMP Armata Pharmaceuticals, Inc. Common Stock | 3.85 USD | 0.00% | +11.92% | -30.51% | -52.88% | 143.15 M USD | ||
| 3708 |  AVXL Anavex Life Sciences Corp. - Common Stock | 1.54 USD | +0.65% | -18.09% | -43.17% | -83.70% | 142.75 M USD | ||
| 3713 |  RNA Atrium Therapeutics, Inc. - Common Stock | 8.26 USD | +4.16% | +0.49% | -20.88% | -88.26% | 141.29 M USD | ||
| 3724 |  OTLK Outlook Therapeutics, Inc. - Common Stock | 0.56 USD | -5.08% | -5.08% | -11.11% | +36.59% | 136.33 M USD | ||
| 3725 |  IPHA Innate Pharma S.A. - American Depositary Shares | 1.48 USD | -2.63% | -5.13% | -22.51% | -25.25% | 138.70 M USD | ||
| 3737 |  TLSA Tiziana Life Sciences Ltd - Common Shares | 1.13 USD | +2.73% | 0.00% | +17.71% | -47.69% | 136.17 M USD | ||
| 3750 |  ADAG Adagene Inc - ADS, each representing 1.25 | 2.78 USD | -1.07% | -6.08% | -21.25% | +40.40% | 131.73 M USD | ||
| 3754 |  SPRB Spruce Biosciences, Inc. - Common Stock | 45.54 USD | +2.57% | +3.20% | -18.11% | -74.38% | 130.88 M USD | ||
| 3762 |  NRXP NRX Pharmaceuticals, Inc. - Common Stock | 2.89 USD | -0.34% | -0.34% | -13.73% | +62.36% | 125.12 M USD | ||
| 3763 |  HUMA Humacyte, Inc. - Common Stock | 0.45 USD | -4.26% | -11.76% | -22.41% | -72.39% | 125.01 M USD | ||
| 3765 |  TNXP Tonix Pharmaceuticals Holding Corp. - Common Stock | 7.28 USD | -3.58% | -21.72% | -41.85% | -51.50% | 124.86 M USD | ||
| 3771 |  HURA TuHURA Biosciences, Inc. - Common Stock | 1.93 USD | -2.53% | -3.02% | -3.98% | -24.90% | 122.99 M USD | ||
| 3775 |  CBUS Cibus, Inc. - Class A Common Stock | 1.59 USD | -1.85% | -2.45% | +1.92% | +5.30% | 121.52 M USD | ||
| 3776 |  TNYA Tenaya Therapeutics, Inc. - Common Stock | 0.54 USD | +1.89% | -5.26% | -18.18% | -75.68% | 121.08 M USD |
Nouvelles Biotechnology Stocks
Le médicament de Pharvaris contre l’angiœdème héréditaire soulage plus vite
Raymond James initie une couverture de Kymera Therapeutics avec une note de surperformance
Raymond James initie la couverture de Nektar avec une note Performance Marché
L’action Palisade Bio initiée à Surperformance par Raymond James
Raymond James réitère sa note sur l’action Liquidia malgré les dépôts juridiques
Tenax Therapeutics suspend temporairement le recrutement dans l’essai LEVEL-2 de TNX-103 afin de modifier les critères ; demande une réunion avec la FDA
Ginkgo Bioworks soutient le programme NSF X-Labs avec son laboratoire
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |